Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Anesthesia for Compartment Syndrome Pain in Healthy Volunteers
NCT04113954Phase 1Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Sep 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mepivacaine in Compartment Syndrome (6 arms), sponsored by Brigham and Women's Hospital. Primary endpoints: Pressure-pain threshold and tolerance at 2 hours, Ischemic pain threshold and tolerance at 2 hours and 1 more. Started Sep 2020; status: completed.
02
Drugs
mepivacaine
03
Conditions
Compartment Syndrome
Beyond the preview
Go deeper on NCT04113954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04113954.